In Vivo Functional Screens Reveal KEAP1 Loss As a Driver of Chemoresistance in Small Cell Lung Cancer

As small cell lung cancer patient-derived xenograft (PDX) models mimic therapeutic responses, scientists performed genetic screens in chemosensitive PDX models to identify drivers of chemoresistance.